The neuroprotective effects of alpha‐lipoic acid on an experimental model of Alzheimer's disease in PC12 cells
Authors:
- 16 June 2021
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 42 (2) , 285-294
Abstract
With the growth of the aging population, the prevalence of Alzheimer's disease (AD) has increased and influenced the work and daily life of AD patients, imposing a heavy burden on society and the patients' families. AD is a progressive disease with a long duration, and the pathogenesis is very complicated. Here, we found that alpha‐lipoic acid (LA), an endogenous, naturally synthesized compound, could attenuate amyloid beta fragment (Aβ25–35)‐induced PC12 cell toxicity. Aβ25–35 treatment largely decreased the viability of PC12 cells, increased reactive oxygen species (ROS) levels, and increased the percentage of apoptotic cells, which were accompanied by changes in the expression of the apoptosis‐related genes. Further, the Wnt pathway was inactivated, and the expression of Wnt pathway‐related proteins such as Frizzled2, GSK3β, and phosphorylated GSK3β were dysregulated after Aβ25–35 treatment. LA efficiently attenuated Aβ25–35‐induced PC12 cell apoptosis and downregulated the phosphorylation‐mediated degradation of β‐catenin as well as GSK3β. Our results demonstrate that LA rescues Aβ25–35‐induced neurocytotoxicity through the Wnt–β‐catenin pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81673227, 81001246)
This publication has 50 references indexed in Scilit:
- WNT/Frizzled signalling: receptor–ligand selectivity with focus on FZD‐G protein signalling and its physiological relevance: IUPHAR Review 3British Journal of Pharmacology, 2014
- Age-Dependent Modulation of Synaptic Plasticity and Insulin Mimetic Effect of Lipoic Acid on a Mouse Model of Alzheimer’s DiseasePLOS ONE, 2013
- Genetics of Alzheimer’s DiseaseBioMed Research International, 2013
- Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer’s diseaseEuropean Journal of Medicinal Chemistry, 2011
- Interruption of β-Catenin Signaling Reduces Neurogenesis in Alzheimer's DiseaseJournal of Neuroscience, 2009
- Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neuronsExperimental Cell Research, 2004
- Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's BrainThe Journal of Neuroscience, 2004
- Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrilsMolecular Psychiatry, 2003
- Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cellsBrain Research, 1977
- Crystalline α-Lipoic Acid: A Catalytic Agent Associated with Pyruvate DehydrogenaseScience, 1951